Skip to content
2000
Volume 24, Issue 2
  • ISSN: 2211-3525
  • E-ISSN: 2211-3533

Abstract

Introduction

BGR-34, a polyherbal formulation, has garnered attention for its antimicrobial properties, attributed to its diverse composition of primary and secondary metabolites.

Objective

The objective of the study was to generate good scientific data regarding BGR-34.

Methods

This study was carried out to investigate the phytochemical screening, High Performance Liquid Chromatography (HPLC) analysis used Quercetin as a standard, and antimicrobial efficacy of BGR-34 against significant human pathogens, including and .

Results and Discussion

The findings revealed a dose-dependent antimicrobial effect, with optimal activity observed at 100 mg/mL, highlighting its potential as a therapeutic agent. The phytochemical screening confirmed the presence of various primary and secondary metabolites, such as flavonoids, alkaloids, saponins, carbohydrates, alkaloids, tannins, proteins, terpenoids, . HPLC analysis demonstrated the presence of quercetin (2.2974 ug/mL), which is responsible for various pharmacological activities. Antimicrobial potential showed activity of BGR-34 against various microbes that are responsible for various diseases. The bioactive compounds in BGR-34, such as phenolics, flavonoids, and terpenoids, exhibit mechanisms like biofilm disruption and microbial membrane interference, underscoring its broad-spectrum efficacy. Furthermore, its potential role in addressing infections related to biofilm-forming pathogens and resistant strains establishes its clinical significance.

Conclusion

These results support the continued exploration of BGR-34 as a viable option in combating microbial infections, with implications for managing resistant pathogens, and reducing the burden of infectious diseases.

Loading

Article metrics loading...

/content/journals/aia/10.2174/0122113525393510250513061353
2025-05-16
2026-03-09
Loading full text...

Full text loading...

References

  1. Diagnosis and classification of diabetes mellitus.Diabetes Care201033Suppl. 1S62S6910.2337/dc10‑S062 20042775
    [Google Scholar]
  2. BandayM.Z. SameerA.S. NissarS. Pathophysiology of diabetes: An overview.Avicenna J. Med.202010417418810.4103/ajm.ajm_53_20 33437689
    [Google Scholar]
  3. OlokobaA.B. ObateruO.A. OlokobaL.B. Type 2 diabetes mellitus: A review of current trends.Oman Med. J.201227426927310.5001/omj.2012.68 23071876
    [Google Scholar]
  4. CareD. Standards of medical care in diabetes.Diab. Care2022451S195
    [Google Scholar]
  5. GeberemeskelG.A. DebebeY.G. NguseN.A. Antidiabetic effect of fenugreek seed powder solution (Trigonella foenum-graecum L.) on hyperlipidemia in diabetic patients.J. Diabetes Res.201920191810.1155/2019/8507453 31583253
    [Google Scholar]
  6. BanaS. KumarN. SartajA. AlhalmiA. QurtamA.A. NasrF.A. Al-ZharaniM. SinghN. GaurP. MishraR. BhardwajS. AliH. GoelR. Rubia cordifolia L. attenuates diabetic neuropathy by inhibiting apoptosis and oxidative stress in rats.Pharmaceuticals20231611158610.3390/ph16111586 38004451
    [Google Scholar]
  7. SinghJ. KakkarP. Antihyperglycemic and antioxidant effect of Berberis aristata root extract and its role in regulating carbohydrate metabolism in diabetic rats.J. Ethnopharmacol.200912312226 19429334
    [Google Scholar]
  8. GuptaS.S. VermaS.C. GargV.P. RaiM. Anti-diabetic effects of Tinospora cardifolia. I. Effect on fasting blood sugar level, glucose tolerance and adrenaline induced hyperglycaemia.Indian J. Med. Res.1967557733745 6056285
    [Google Scholar]
  9. DhanabalS.P. KokateC.K. RamanathanM. KumarE.P. SureshB. Hypoglycaemic activity of Pterocarpus marsupium Roxb.Phytother. Res.20062014810.1002/ptr.1819 16397913
    [Google Scholar]
  10. BaskaranK. AhamathB.K. ShanmugasundaramK.R. ShanmugasundaramE.R.B. Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients.J. Ethnopharmacol.199030329530510.1016/0378‑8741(90)90108‑6 2259217
    [Google Scholar]
  11. KhanJ.T. RichiA.E. RijuS.A. JalalT. OrchiR.J. SinghS. BhagatP. Abdel-WahabY.H.A. AnsariP. Evaluation of antidiabetic potential of Mangifera indica leaf in streptozotocin-induced type 2 diabetic rats: Focus on glycemic control and cholesterol regulation.Endocrines20245213715210.3390/endocrines5020010
    [Google Scholar]
  12. SunarwidhiA.L. SudarsonoS. NugrohoA.E. Hypoglycemic effect of combination of Azadirachta indica A. Juss. and Gynura procumbens (Lour.) Merr. ethanolic extracts standardized by rutin and quercetin in alloxan-induced hyperglycemic rats.Adv. Pharm. Bull201442(Suppl. 2) 613-618 25671197
    [Google Scholar]
  13. MayankK. ManjulP.S. Pharmacognostical standardization and pharmacological potential of Elaeocarpus ganitrus leaves as an antiulcer agent.Int. J. Pharm. Sci. Nanotechnol.201811441624169
    [Google Scholar]
  14. KulshreshthaM. DwivediH. SinghM. Antimicrobial effects of leaves of Indian herbal plants with reference to peptic ulcer.Environ. Dis.201831182610.4103/ed.ed_18_17
    [Google Scholar]
  15. RituparnaC. BhavtaranS. NarendraP. Dipeptidyl peptidase- IV inhibitory activity of Berberis aristata.J. Nat. Prod.20114158163
    [Google Scholar]
  16. SangeethaM.K. Balaji RaghavendranH.R. GayathriV. VasanthiH.R. Tinospora cordifolia attenuates oxidative stress and distorted carbohydrate metabolism in experimentally induced type 2 diabetes in rats.J. Nat. Med.2011653-454455010.1007/s11418‑011‑0538‑6 21538233
    [Google Scholar]
  17. AhmadF. KhalidP. KhanM.M. RastogiA.K. KidwaiJ.R. Insulin like activity in (−) epicatechin.Acta Diabetol. Lat.198926429130010.1007/BF02624640 2698039
    [Google Scholar]
  18. VijayanandR. AralelimathS. BhiseaB. Anti-diabetic effects of gymnema sylvester extract on streptozotocin induced diabetic rats and possible β-cell protective and regenerative evaluations.Dig. J. Nanomater. Biostruct.201271135142
    [Google Scholar]
  19. SandhyaR. PallaviM. SureshK. SureshJ. ShankarP. AniketK. Antiglycation, antioxidant and antidiabetic activity of traditional medicinal plant: Rubia cordifolia Linn. For management of hyperglycemia.Int. J. Plant Animal Environ. Sci.20132133-44249
    [Google Scholar]
  20. PatelD.K. PrasadS.K. KumarR. HemalathaS. An overview on antidiabetic medicinal plants having insulin mimetic property.Asian Pac. J. Trop. Biomed.20122432033010.1016/S2221‑1691(12)60032‑X 23569923
    [Google Scholar]
  21. JondleC.N. GuptaK. MishraB.B. SharmaJ. Klebsiella pneumoniae infection of murine neutrophils impairs their efferocytic clearance by modulating cell death machinery.PLoS Pathog.20181410e100733810.1371/journal.ppat.1007338 30273394
    [Google Scholar]
  22. AghamohammadS. BadmastiF. SolgiH. AminzadehZ. KhodabandeloZ. ShahcheraghiF. First report of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae among fecal carriage in Iran: High diversity of clonal relatedness and virulence factor profiles.Microb. Drug Resist.202026326126910.1089/mdr.2018.0181 30277830
    [Google Scholar]
  23. LiuC. GuoJ. Characteristics of ventilator-associated pneumonia due to hypervirulent Klebsiella pneumoniae genotype in genetic back-ground for the elderly in two tertiary hospitals in China.Antimicrob. Resist. Infect. Control201879510.1186/s13756‑018‑0371‑8 30128143
    [Google Scholar]
  24. MitharwalS.M. YaddanapudiS. BhardwajN. GautamV. BiswalM. YaddanapudiL. Intensive care unit-acquired infections in a tertiary care hospital: An epidemiologic survey and influence on patient outcomes.Am. J. Infect. Control2016447e113e11710.1016/j.ajic.2016.01.021 26944004
    [Google Scholar]
  25. LiuW.C. LiS.B. ZhangC.F. CuiX.H. Severe pneumonia and acute myocardial infarction complicated with pericarditis after percuta-neous coronary intervention: A case report.World J. Clin. Cases202210103222323110.12998/wjcc.v10.i10.3222 35647136
    [Google Scholar]
  26. ChowdhuryF. RossA.G. IslamM.T. McMillanN.A.J. QadriF. Diagnosis, management, and future control of cholera.Clin. Microbiol. Rev.2022353e00211e0022110.1128/cmr.00211‑21 35726607
    [Google Scholar]
  27. KanungoS. AzmanA.S. RamamurthyT. DeenJ. DuttaS. Cholera.Lancet2022399103331429144010.1016/S0140‑6736(22)00330‑0 35397865
    [Google Scholar]
  28. LeonF. BaduiE. CamposA. EncisoR. FakihT. GuadarramaM. ValdespinoA. MurilloH. CallejaC. Cholera and myocarditis: A case report.Angiology1997486545549 9194541
    [Google Scholar]
  29. HamoryB.H. ParisiJ.T. HuttonJ.P. Staphylococcus epidermidis: A significant nosocomial pathogen.Am. J. Infect. Control1987152597410.1016/0196‑6553(87)90003‑4 3555174
    [Google Scholar]
  30. ZhengC.X. MaX.F. ZhangY.H. LiH.J. ZhangG.F. Research progress in the mechanism of translation initiation of eukaryotic mRNAs.Yi Chuan201840860761910.16288/j.yczz.17‑393 30117417
    [Google Scholar]
  31. World Organisation for Animal Health2018Available from: https://www.woah.org/en/home/
  32. European Food Safety Authority and European Centre for Disease Prevention and Control (EFSA and ECDC)The European union one health 2018 zoonoses report.EFSA J.20191712e05926 32626211
    [Google Scholar]
  33. LalaniT. KanafaniZ.A. ChuV.H. MooreL. CoreyG.R. PappasP. WoodsC.W. CabellC.H. HoenB. Selton-SutyC. Doco-LecompteT. ChirouzeC. RaoultD. MiroJ.M. MestresC.A. OlaisonL. EykynS. AbrutynE. FowlerV.G. Prosthetic valve endocarditis due to coagulase-negative staphylococci: Findings from the international collaboration on endocarditis merged database.Eur. J. Clin. Microbiol. Infect. Dis.200625636536810.1007/s10096‑006‑0141‑z 16767483
    [Google Scholar]
  34. ChuV.H. CabellC.H. AbrutynE. CoreyG.R. HoenB. MiroJ.M. OlaisonL. StryjewskiM.E. PappasP. AnstromK.J. EykynS. HabibG. BenitoN. FowlerV.G. Native valve endocarditis due to coagulase-negative staphylococci: Report of 99 episodes from the International Collaboration on Endocarditis Merged Database.Clin. Infect. Dis.200439101527153010.1086/424878 15546091
    [Google Scholar]
  35. LópezJ. RevillaA. VilacostaI. VillacortaE. González-JuanateyC. GómezI. RollánM.J. San RománJ.A. Definition, clinical profile, microbiological spectrum, and prognostic factors of early-onset prosthetic valve endocarditis.Eur. Heart J.200728676076510.1093/eurheartj/ehl486 17255216
    [Google Scholar]
  36. CahillT.J. PrendergastB.D. Infective endocarditis.Lancet20163871002188289310.1016/S0140‑6736(15)00067‑7 26341945
    [Google Scholar]
  37. AntolínJ. GutierrezA. SegovianoR. LópezR. CiguenzaR. Endocarditis due to Listeria: Description of two cases and review of the literature.Eur. J. Intern. Med.200819429529610.1016/j.ejim.2007.06.020 18471682
    [Google Scholar]
  38. BhuttaZ.A. Current concepts in the diagnosis and treatment of typhoid fever.BMJ20063337558788210.1136/bmj.333.7558.78 16825230
    [Google Scholar]
  39. LemosJ.A. PalmerS.R. ZengL. WenZ.T. KajfaszJ.K. FreiresI.A. AbranchesJ. BradyL.J. The biology of Streptococcus mutans. Microbiol. Spectr.2019717.1.0310.1128/microbiolspec.GPP3‑0051‑2018 30657107
    [Google Scholar]
/content/journals/aia/10.2174/0122113525393510250513061353
Loading
/content/journals/aia/10.2174/0122113525393510250513061353
Loading

Data & Media loading...


  • Article Type:
    Research Article
Keyword(s): antimicrobial; antioxidant; BGR-34; flavonoids; HPLC; Klebsiella pneumoniae
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test